Learn more

IMMUNOLIGHT LLC

Overview
  • Total Patents
    223
  • GoodIP Patent Rank
    9,342
  • Filing trend
    ⇩ 31.0%
About

IMMUNOLIGHT LLC has a total of 223 patent applications. It decreased the IP activity by 31.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and basic materials chemistry are LIGHT SCIENCES CORP, PHOTODYNAMIC INC and TRITON BIOSYSTEMS INC.

Patent filings per year

Chart showing IMMUNOLIGHT LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Walder Harold 119
#2 Fathi Zakaryae 95
#3 Bourke Jr Frederic A 64
#4 Bourke Frederic A 57
#5 Bourke Frederic A Jr 48
#6 Vo-Dinh Tuan 42
#7 Beyer Wayne F 31
#8 Adamson Justus 29
#9 Oldham Mark 29
#10 Therien Michael J 20

Latest patents

Publication Filing date Title
WO2020180426A1 Energy augmentation structures, energy emitters or energy collectors containing the same, and their use in methods and systems for treating cell proliferation disorders
US2020114164A1 Methods, devices, and compositions for measuring and inducing cell-to-cell communication, and therapeutic uses thereof
WO2019014413A1 Methods for radiotherapy to trigger light activated drugs
US2018344850A1 X-ray psoralen activated cancer therapy (x-pact) with associated treatments
US2018154178A1 Phosphor-containing drug activator activatable by a Monte Carlo derived x-ray exposure, system containing the activator, and methods for use
US2019184190A1 Phosphor-containing drug activator activatable by a monte carlo derived x-ray exposure, system containing the activator, and methods for use
KR20190014504A Insert devices and systems for the production of emission light in media and methods of use thereof
US2018269174A1 Adhesive bonding composition and electronic components prepared from the same
US2017157418A1 X-ray psoralen activated cancer therapy (X-PACT)
CN108778417A The drug activation agent of phosphor-containing, its suspension, system and application method comprising suspension
CA3003270A1 Methods for radiotherapy to trigger light activation drugs
EP3365017A1 X-ray psoralen activated cancer therapy (x-pact)
AU2016210665A1 Methods and systems for treating cell proliferation disorders
US2016362534A1 On demand radiation induced constructive and deconstructive chemical reactions
WO2016205167A1 On demand radiation induced constructive and deconstructive chemical reactions
AU2016206832A1 Non-invasive systems and methods for treatment of a host carrying a virus with photoactivatable drugs
US2017239489A1 Non-invasive systems and methods for selective activation of photoreactive responses
WO2016003888A1 Improved adhesive bonding composition and method of use
US2017154866A1 Adhesive bonding composition and method of use
WO2015195896A1 Methods and systems for treating cell proliferation disorders with psoralen derivatives